E-LIB Suche - Ergebnisse für: Cruz, Josefina

1

Long-term patient-reported outcomes from monarchE: Abemacic..:

Tolaney, Sara M. ; Guarneri, Valentina ; Seo, Jae Hong...
European Journal of Cancer. 199 (2024) - p. 113555 , 2024

2

Patritumab deruxtecan in HER2-negative breast cancer: part ..:

Brasó-Maristany, Fara ; Ferrero-Cafiero, Juan Manuel ; Falato, Claudette...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Corrigendum to 'Chemotherapy in patients with localized ang..:

Conforti, Fabio ; Gronchi, Alessandro ; Penel, Nicholas...
European Journal of Cancer. 184 (2023) - p. 197-198 , 2023

Link: https://doi.org/10.1016/..

4

Long-term outcomes of high-risk HR-positive and HER2-negati..:

Martín, Miguel ; Carrasco, Eva ; Rodríguez-Lescure, Álvaro...
Breast Cancer Research and Treatment. 201 (2023) 2 - p. 151-159 , 2023

Link: https://doi.org/10.1007/..

5

Chemotherapy in patients with localized angiosarcoma of any..:

Conforti, Fabio ; Gronchi, Alessandro ; Penel, Nicholas...
European Journal of Cancer. 171 (2022) - p. 183-192 , 2022

Link: https://doi.org/10.1016/..

6

Preference for the fixed-dose combination of pertuzumab and..:

O'Shaughnessy, Joyce ; Sousa, Susana ; Cruz, Josefina...
European Journal of Cancer. 152 (2021) - p. 223-232 , 2021

Link: https://doi.org/10.1016/..

7

SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity ..:

Pascual, Tomás ; Oliveira, Mafalda ; Ciruelos, Eva...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

8

GEICAM Guidelines for the Management of Patients with Breas..:

Martin, Miguel ; Guerrero-Zotano, Angel ; Montero, Ángel...
The Oncologist. 25 (2020) 9 - p. e1339-e1345 , 2020

Link: https://doi.org/10.1634/..

9

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS..:

Gronchi, Alessandro ; Hindi, Nadia ; Cruz, Josefina...
EClinicalMedicine. 9 (2019) - p. 35-43 , 2019

Link: https://doi.org/10.1016/..

10

Development and validation of a sexual relations satisfacti..:

Mancha, Rosario González ; Muñoz, Montserrat ; de la Cruz-Merino, Luis...
Health and Quality of Life Outcomes. 17 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

11

Phase III evaluating the addition of fulvestrant (F) to ana..:

Ruíz-Borrego, Manuel ; Guerrero-Zotano, Angel ; Bermejo, Begoña...
Breast Cancer Research and Treatment. 177 (2019) 1 - p. 115-125 , 2019

Link: https://doi.org/10.1007/..

12

Relevance of Reference Centers in Sarcoma Care and Quality ..:

Martin-Broto, Javier ; Hindi, Nadia ; Cruz, Josefina...
The Oncologist. 24 (2018) 6 - p. e338-e346 , 2018

Link: https://doi.org/10.1634/..

13

Malignant bone tumors (other than Ewing's): clinical practi..:

Redondo, Andrés ; Bagué, Silvia ; Bernabeu, Daniel...
Cancer Chemotherapy and Pharmacology. 80 (2017) 6 - p. 1113-1131 , 2017

Link: https://doi.org/10.1007/..

14

Role of Surgery in Patients with Recurrent, Metastatic, or ..:

the Spanish Group for Research on Sarcoma (GEIS) ; Rubió-Casadevall, Jordi ; Martinez-Trufero, Javier...
Annals of Surgical Oncology. 22 (2015) 9 - p. 2948-2957 , 2015

Link: https://doi.org/10.1245/..

15

Clinical practice guidelines for the diagnosis and treatmen..:

Garcia del Muro, Xavier ; de Alava, Enrique ; Artigas, Vicenç...
Cancer Chemotherapy and Pharmacology. 77 (2015) 1 - p. 133-146 , 2015

Link: https://doi.org/10.1007/..